Bioenergy RIBOSE™ in Fibromyalgia (FMS) and Chronic Fatigue Syndrome (CFS)
The muscle in patients with FMS and CFS is generally severely energy starved. This lack of energy leads to a number of physiological reactions within the muscle cell, ending in debilitating fatigue, muscle pain, soreness, and stiffness. By increasing the energy level in affected muscle, Bioenergy RIBOSE helps patients overcome fatigue, and lessens the pain associated with their conditions.
Dr. Jacob Teitelbaum, Medical Director of the Fibromyalgia and Fatigue Centers of America, has conducted independent research on this effect. In his research, Dr. Teitelbaum found that 65% of patients treated with Bioenergy RIBOSE showed a significant improvement in symptoms, with an average increase in energy of 45%. Dr. Teitelbaum calls this result, "Outstanding for a single entity product."
For more information on Bioenergy RIBOSE in FMS and CFS, please refer to the following:
D-Ribose in Fibromyalgia and Neuromuscular Disease - White Paper (PDF)
Benjamin Gebhart, Pharm.D., and James A. Jorgenson, M.S., FASHP. Benefit of Ribose in a Patient with Fibromyalgia Pharmacotherapy 2004;24(11):1646-1648 - Full Article (PDF)
Jacob E. Teitelbaum, MD, CA Johnson, JA St.Cyr MD,PhD. Effective Treatment Of Chronic Fatigue Syndrome And Fibromyalgia With D-Ribose J Alt Comp Med, 2006;12(6):857-862. Full Article (PDF)